A carregar...
Denosumab Induced Severe Hypocalcemia in a Patient With Metastatic Prostate Cancer
Background: Denosumab can lead to severe hypocalcemia in patients with underlying risk factors such as vitamin D deficiency, low PTH, hypomagnesemia, and CKD. Denosumab is a monoclonal antibody against RANKL, reducing the activity of osteoclasts and thus reducing the release of calcium in the bloods...
Na minha lista:
| Publicado no: | J Endocr Soc |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8090016/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.384 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|